Medify vs Aptavia — compared
Medify is a large UK-founded admissions-prep platform whose ANZ subscription bundles GAMSAT with UCAT and interview prep — strong on question volume and mocks at a low subscription price. Aptavia is GAMSAT-only and AI-first: instant dual-examiner essay marking, adaptive practice and a plan. Dated, sourced facts below; fit notes at the end.
When Medify fits
You're preparing for UCAT as well as (or instead of) GAMSAT and want one cheap subscription across both, you mainly want a big bank of questions and mocks to grind through, and you don't need your essays marked.
When we fit
Section II matters to your score (it's a third of the unweighted picture and un-practisable without feedback), you want marking you can iterate against the same hour, and you want practice that targets your weakest reasoning strand rather than a bank to wade through. We publish our marking-consistency evidence; nobody has to take the AI's word for it.
The cheapest way to compare is first-hand: 3 days of Pro free, no card — or get your first essay marked free, saved to your own account.
Medify is a trademark of its owner; no affiliation or endorsement is implied. GAMSAT® is a registered trademark of ACER. ACER is not affiliated with, and does not endorse, Aptavia. Corrections: contact@aptavia.com.au